101 related articles for article (PubMed ID: 23246780)
1. Cancer cell targeting and imaging with biopolymer-based nanodevices.
Hajdu I; Bodnár M; Trencsényi G; Márián T; Vámosi G; Kollár J; Borbély J
Int J Pharm; 2013 Jan; 441(1-2):234-41. PubMed ID: 23246780
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific localization of self-assembled nanoparticle PET/MR modalities.
Hajdu I; Trencsényi G; Bodnár M; Emri M; Bánfalvi G; Sikula J; Márián T; Kollár J; Vámosi G; Borbély J
Anticancer Res; 2014 Jan; 34(1):49-59. PubMed ID: 24403444
[TBL] [Abstract][Full Text] [Related]
3. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
4. (99m)Tc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities.
Polyák A; Hajdu I; Bodnár M; Trencsényi G; Pöstényi Z; Haász V; Jánoki G; Jánoki GA; Balogh L; Borbély J
Int J Pharm; 2013 Jun; 449(1-2):10-7. PubMed ID: 23562750
[TBL] [Abstract][Full Text] [Related]
5. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel folate conjugated fluorescent nanoparticles for tumor imaging.
Hou J; Zhang Q; Li X; Tang Y; Cao MR; Bai F; Shi Q; Yang CH; Kong DL; Bai G
J Biomed Mater Res A; 2011 Dec; 99(4):684-9. PubMed ID: 21913319
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
9. Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging.
Bhattacharya D; Das M; Mishra D; Banerjee I; Sahu SK; Maiti TK; Pramanik P
Nanoscale; 2011 Apr; 3(4):1653-62. PubMed ID: 21331392
[TBL] [Abstract][Full Text] [Related]
10. Electrostatically assembled biocompatible polymer nanoparticles for MR/optical dual-modality imaging nanoprobes.
Chung KH; Cho MY; Sung MH; Poo H; Lim YT
Chem Commun (Camb); 2011 Aug; 47(31):8889-91. PubMed ID: 21748163
[TBL] [Abstract][Full Text] [Related]
11. Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI.
Chen TJ; Cheng TH; Hung YC; Lin KT; Liu GC; Wang YM
J Biomed Mater Res A; 2008 Oct; 87(1):165-75. PubMed ID: 18085650
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of
Körhegyi Z; Rózsa D; Hajdu I; Bodnár M; Kertész I; Kerekes K; Kun S; Kollár J; Varga J; Garai I; Trencsényi G; Borbély J
Anticancer Res; 2019 May; 39(5):2415-2427. PubMed ID: 31092434
[TBL] [Abstract][Full Text] [Related]
14. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Choi H; Choi SR; Zhou R; Kung HF; Chen IW
Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
[TBL] [Abstract][Full Text] [Related]
15. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
[TBL] [Abstract][Full Text] [Related]
16. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
Nam T; Park S; Lee SY; Park K; Choi K; Song IC; Han MH; Leary JJ; Yuk SA; Kwon IC; Kim K; Jeong SY
Bioconjug Chem; 2010 Apr; 21(4):578-82. PubMed ID: 20201550
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
18. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.
Ashokan A; Menon D; Nair S; Koyakutty M
Biomaterials; 2010 Mar; 31(9):2606-16. PubMed ID: 20035998
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging.
Zhou L; Zheng X; Gu Z; Yin W; Zhang X; Ruan L; Yang Y; Hu Z; Zhao Y
Biomaterials; 2014 Aug; 35(26):7666-78. PubMed ID: 24929618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
